KinaRx, Inc.
Biotechnology company · Rockville, Maryland, United States
KinaRx, Inc. is a biotechnology company headquartered in Rockville, Maryland, United States. Its earliest recorded incorporation is in 2017. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.4 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $50,000 sold in a notice filed in 2022.
KinaRx at a glance
What does KinaRx do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.4 million in total (2020). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $50,000 sold (2022).
Frequently asked questions about KinaRx
Where is KinaRx headquartered?
KinaRx, Inc. is headquartered in Rockville, Maryland, United States.
What does KinaRx do?
KinaRx, Inc. is a biotechnology company.
When was KinaRx founded?
The earliest incorporation on record for KinaRx, Inc. is in 2017, according to public company registers.
Similar companies
- REGENXBIO Inc.Rockville, Maryland, United States
- Immunomic Therapeutics, Inc.Rockville, Maryland, United States
- OncoC4, Inc.Rockville, Maryland, United States
- Integrated Biotherapeutics LLCRockville, Maryland, United States
- Sanaria Inc.Rockville, Maryland, United States
- CASI Pharmaceuticals, Inc (DE)Rockville, Maryland, United States
- OncoImmune, Inc.Rockville, Maryland, United States
- Rise Therapeutics, LLCRockville, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences